Therefore, it is plausible that individuals who are homozygous or show compound heterozygosity for each of the minor alleles of these 60 pathogenetic variants will likely have lower levels of in vivo DNase I activity than individuals with other genotypes, thus being at potential risk of developing autoimmune dysfunction such as SLE. Here, DNASE1L3 is linked to systemic lupus erythematosus.